While the previous reports from the preclinical studies and the most recent reports from the transgenic mouse models demonstrate increased metastasis in the breast, liver, prostate, and lung (NSCLC) cancers with Akt1 suppression, the cBioportal analysis provides reasonable, if not complete evidence indicating the existence of such a phenomenon in human PCa patients as well. The gene discussed is AKT1; the disease is posterior cortical atrophy.